Search Results - "Diasio, R"

Refine Results
  1. 1

    Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing by Caudle, K E, Thorn, C F, Klein, T E, Swen, J J, McLeod, H L, Diasio, R B, Schwab, M

    Published in Clinical pharmacology and therapeutics (01-12-2013)
    “…The fluoropyrimidines are the mainstay chemotherapeutic agents for the treatment of many types of cancers. Detoxifying metabolism of fluoropyrimidines requires…”
    Get full text
    Journal Article
  2. 2

    A DPYD Variant (Y186C) in Individuals of African Ancestry Is Associated With Reduced DPD Enzyme Activity by Offer, S M, Lee, A M, Mattison, L K, Fossum, C, Wegner, N J, Diasio, R B

    Published in Clinical pharmacology and therapeutics (01-07-2013)
    “…5‐Fluorouracil (5‐FU) is used to treat many aggressive cancers, such as those of the colon, breast, and head and neck. The responses to 5‐FU, with respect to…”
    Get full text
    Journal Article
  3. 3

    Quantitative Contribution of rs75017182 to Dihydropyrimidine Dehydrogenase mRNA Splicing and Enzyme Activity by Nie, Q, Shrestha, S, Tapper, EE, Trogstad‐Isaacson, CS, Bouchonville, KJ, Lee, AM, Wu, R, Jerde, CR, Wang, Z, Kubica, PA, Offer, SM, Diasio, RB

    Published in Clinical pharmacology and therapeutics (01-10-2017)
    “…Dihydropyrimidine dehydrogenase (DPD; DPYD gene) variants have emerged as reliable predictors of adverse toxicity to the chemotherapy agent 5‐fluorouracil…”
    Get full text
    Journal Article
  4. 4

    Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5‐Fluorouracil Sensitivity in an East African Population by Elraiyah, T, Jerde, CR, Shrestha, S, Wu, R, Nie, Q, Giama, NH, Sarangi, V, Roberts, LR, Offer, SM, Diasio, RB

    Published in Clinical pharmacology and therapeutics (01-03-2017)
    “…Clinical studies have identified specific genetic variants in dihydropyrimidine dehydrogenase (DPD; DPYD gene) as predictors of severe adverse toxicity to the…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Colorectal Tumors Responding to 5-Fluorouracil Have Low Gene Expression Levels of Dihydropyrimidine Dehydrogenase, Thymidylate Synthase, and Thymidine Phosphorylase by SALONGA, D, DANENBERG, K. D, DANENBERG, P. V, JOHNSON, M, METZGER, R, GROSHEN, S, TSAO-WEI, D. D, LENZ, H.-J, LEICHMAN, C. G, LEICHMAN, L, DIASIO, R. B

    Published in Clinical cancer research (01-04-2000)
    “…We had previously shown that high gene expressions (mRNA levels) of thymidylate synthase ( TS ; Leichman et al. , J. Clin. Oncol., 15: 3223–3229, 1997) and…”
    Get full text
    Journal Article
  8. 8

    Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy by Witzig, T E, Hu, G, Offer, S M, Wellik, L E, Han, J J, Stenson, M J, Dogan, A, Diasio, R B, Gupta, M

    Published in Leukemia (01-01-2014)
    “…Protein tyrosine phosphatases such as PTPN6 can be downregulated in various neoplasms. PTPN6 expression by immunohistochemistry in 40 diffuse large B-cell…”
    Get full text
    Journal Article
  9. 9

    Life-Threatening Toxicity in a Dihydropyrimidine Dehydrogenase-deficient Patient after Treatment with Topical 5-Fluorouracil by JOHNSON, M. R, HAGEBOUTROS, A, KANGSHENG WANG, HIGH, L, SMITH, J. B, DIASIO, R. B

    Published in Clinical cancer research (01-08-1999)
    “…In humans, 80–90% of an administered dose of 5-fluorouracil (5-FU) is degraded by dihydropyrimidine dehydrogenase (DPD; EC 1.3.1.2), the initial…”
    Get full text
    Journal Article
  10. 10

    Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma by Greenberg, A J, Lee, A M, Serie, D J, McDonnell, S K, Cerhan, J R, Liebow, M, Larson, D R, Colby, C L, Norman, A D, Kyle, R A, Kumar, S, Rajkumar, S V, Diasio, R B, Slager, S L, Vachon, C M

    Published in Leukemia (01-02-2013)
    “…Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant precursor to multiple myeloma (MM). Though several genetic variants have been…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver : population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy by LU, Z, ZHANG, R, DIASIO, R. B

    Published in Cancer research (Chicago, Ill.) (15-11-1993)
    “…Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (FUra), one of the most widely used…”
    Get full text
    Journal Article
  13. 13

    Sorivudine and 5‐fluorouracil; a clinically significant drug‐drug interaction due to inhibition of dihydropyrimidine dehydrogenase by Diasio, Robert B.

    Published in British journal of clinical pharmacology (01-07-1998)
    “…Sorivudine (1‐β‐d‐arabinofuranosyl‐E‐5‐[2‐bromovinyl] uracil; BV‐araU; SQ32,756) is an antimetabolite which is a synthetic analogue of thymidine. This drug has…”
    Get full text
    Journal Article
  14. 14

    Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy by ZHIHONG LU, RUIWEN ZHANG, CARPENTER, J. T, DIASIO, R. B

    Published in Clinical cancer research (01-02-1998)
    “…Dihydropyrimidine dehydrogenase (DPD) is the initial, rate-limiting enzyme in the catabolism of 5-fluorouracil (5-FU), one of the most widely used…”
    Get full text
    Journal Article
  15. 15

    Clinical pharmacology of 5-fluorouracil by DIASIO, R. B, HARRIS, B. E

    Published in Clinical pharmacokinetics (01-04-1989)
    “…5-Fluorouracil, first introduced as a rationally synthesized anticancer agent 30 years ago, continues to be widely used in the management of several common…”
    Get full text
    Journal Article
  16. 16

    Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy by JIANG, W, LU, Z, HE, Y, DIASIO, R. B

    Published in Clinical cancer research (01-03-1997)
    “…Dihydropyrimidine dehydrogenase (DPD) is the initial, rate-limiting enzyme in the catabolism of 5-fluorouracil, one of the most widely used cancer…”
    Get full text
    Journal Article
  17. 17

    Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency by C H Takimoto, Z H Lu, R Zhang, M D Liang, L V Larson, L R Cantilena, Jr, J L Grem, C J Allegra, R B Diasio, E Chu

    Published in Clinical cancer research (01-03-1996)
    “…Patients with decreased dihydropyrimidine dehydrogenase (DPD) activity are at increased risk for experiencing serious adverse reactions following…”
    Get full text
    Journal Article
  18. 18

    Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase by FALANY, C. N, JOHNSON, M. R, BARNES, S, DIASIO, R. B

    Published in The Journal of biological chemistry (29-07-1994)
    “…In order to establish whether a single enzyme in human liver was capable of conjugating bile acids with both glycine and taurine, a cDNA encoding human liver…”
    Get full text
    Journal Article
  19. 19

    Quantitation of Dihydropyrimidine Dehydrogenase Expression by Real-Time Reverse Transcription Polymerase Chain Reaction by Johnson, Martin R., Wang, Kangsheng, Smith, Jeffrey B., Heslin, Martin J., Diasio, Robert B.

    Published in Analytical biochemistry (15-02-2000)
    “…Several recent studies have reported a correlation between intratumor dihydropyrimidine dehydrogenase (DPD) messenger RNA (mRNA) levels and sensitivity to…”
    Get full text
    Journal Article
  20. 20